This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SXC Health Solutions' CEO Discusses Q1 2012 Results - Earnings Call Transcript

SXC Health Solutions (SXCI)

Q1 2012 Earnings Call

May 03, 2012 8:30 am ET

Executives

Mark A. Thierer - Chairman and Chief Executive Officer

Jeffrey Park - Chief Financial Officer, Principal Accounting Officer and Executive Vice President of Finance

Analysts

Bret D. Jones - Oppenheimer & Co. Inc., Research Division

Lawrence C. Marsh - Barclays Capital, Research Division

Andrew Schenker - Morgan Stanley, Research Division

George Hill - Citigroup Inc, Research Division

Brian Tanquilut - Jefferies & Company, Inc., Research Division

Brooks G. O'Neil - Dougherty & Company LLC, Research Division

Amanda Murphy - William Blair & Company L.L.C., Research Division

Robert M. Willoughby - BofA Merrill Lynch, Research Division

Presentation

Operator

Good morning, ladies and gentlemen. Thank you for standing by. Welcome to the SXC Health Solutions 2012 First Quarter Results Conference Call. The company issued an earnings press release this morning, which has been filed with the SEC on Form 8-K and is also available on the Investor Information section of SXC's website at sxc.com. Listeners are reminded that portions of today's discussions contain forward-looking statements that reflect current views with respect to future events such as SXC's outlook for future performance and the closing of the pending Catalyst transaction. Any such statements are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those projected in the forward-looking statements. Please refer to the company's filings with the SEC for additional information on risk factors. We would also like to advise you that all forward-looking statements made on today's call are intended to fall within the Safe Harbor provisions of the Private Securities and Litigation Reform Act of 1995.

During the call, we will also discuss some items that do not conform to generally accepted accounting principles, including EBITDA and adjusted EPS. We have reconciled those items to the most comparable GAAP measures in the earnings release and in the Form 10-Q that will be filed with the SEC. Neither EBITDA nor adjusted EPS should be considered as an alternative to net income or cash flows from operating activities or any other performance or liquidity measure derived in accordance with GAAP.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,077.51 -2.63 -0.01%
S&P 500 2,114.27 -3.42 -0.16%
NASDAQ 5,070.4930 -21.5920 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs